Treatment of metastatic carcinoid tumours, phaeochromocytoma, paraganglioma and medullary carcinoma of the thyroid with (131)I-meta-iodobenzylguanidine [(131)I-mIBG].

Treatment of metastatic carcinoid tumours, phaeochromocytoma, paraganglioma and medullary carcinoma of the thyroid with (131)I-meta-iodobenzylguanidine [(131)I-mIBG].

OBJECTIVE: Meta-iodo-benzyl-guanidine labelled with 131-iodine [(131)I-mIBG] has been used extensively for imaging tumours originating from the neural crest but experience with its therapeutic use is limited, particularly for non-catecholamine secreting tumours. In order to assess the therapeutic re...

Bibliografski detalji
Glavni autori:	Mukherjee, J, Kaltsas, G, Islam, N, Plowman, P, Foley, R, Hikmat, J, Britton, K, Jenkins, P, Chew, S, Monson, J, Besser, G, Grossman, AB
Format:	Journal article
Jezik:	English
Izdano:	2001

Slični predmeti

Treatment of metastatic pheochromocytoma and paraganglioma with I-131-meta-iodobenzylguanidine (MIBG)
od: Kaltsas, G, i dr.
Izdano: (2003)

Treatment of malignant phaeochromocytoma, paraganglioma and carcinoid tumours with 131I-metaiodobenzylguanidine.
od: Bomanji, J, i dr.
Izdano: (1993)

Peptide Receptor Radionuclide Treatment and (131)I-MIBG in the management of patients with metastatic/progressive phaeochromocytomas and paragangliomas
od: Nastos, K, i dr.
Izdano: (2017)

Sequelae and survivorship in patients treated with (131)I-MIBG therapy.
od: Sze, W, i dr.
Izdano: (2013)

Sequelae and survivorship in patients treated with 131 I-MIBG therapy
od: Sze, W, i dr.
Izdano: (2013)

Ocular metastases secondary to carcinoid tumors: the utility of imaging with [(123)I]meta-iodobenzylguanidine and [(111)In]DTPA pentetreotide.
od: Isidori, A, i dr.
Izdano: (2002)

Improved outcome of 131I-mIBG treatment through combination with external beam radiotherapy in the SK-N-SH mouse model of neuroblastoma
od: Corroyer-Dulmont, A, i dr.
Izdano: (2017)

I-123 imaging for the prediction of I-131 therapy for recurrent differentiated thyroid cancer, RDTC, when I-131 tracer is negative but raised thyroglobulin, Tg
od: Britton, K, i dr.
Izdano: (1999)

The diagnosis and management of malignant phaeochromocytoma and paraganglioma.
od: Chrisoulidou, A, i dr.
Izdano: (2007)

Carcinoid tumours presenting as breast cancer: the utility of radionuclide imaging with 123I-MIBG and 111In-DTPA pentetreotide.
od: Kaltsas, G, i dr.
Izdano: (1998)

Routine preoperative (123)I-MIBG scintigraphy for patients with phaeochromocytoma is not necessary.
od: Mihai, R, i dr.
Izdano: (2008)

The management of differentiated thyroid cancer using 123I for imaging to assess the need for 131I therapy.
od: Ali, N, i dr.
Izdano: (2006)

I131-MIBG treatment revisited: How important is scheduling when combined with external beam irradiation?
od: Corroyer-Dulmont, A, i dr.
Izdano: (2016)

123I-metaiodobenzylguanidine (MIBG) scintigraphy for the detection of adrenal and extra-adrenal phaeochromocytomas: CT and MRI correlation.
od: Bhatia, K, i dr.
Izdano: (2008)

MIBG scans for phaeochromocytoma: time to abandon the technique?
od: Grossman, A, i dr.
Izdano: (2009)

The role of 123I-diagnostic imaging in the follow-up of patients with differentiated thyroid carcinoma as compared to 131I-scanning: avoidance of negative therapeutic uptake due to stunning.
od: Siddiqi, A, i dr.
Izdano: (2001)

Naloxone provokes catecholamine release in phaeochromocytomas and paragangliomas.
od: Bouloux, P, i dr.
Izdano: (1986)

The clinical presentation (symptoms and signs) of sporadic and familial chromaffin cell tumours (phaeochromocytomas and paragangliomas).
od: Kaltsas, G, i dr.
Izdano: (2004)

Dopamine-secreting phaeochromocytomas and paragangliomas: clinical features and management
od: Foo, S.H., i dr.
Izdano: (2010)

NMR-ON MEASUREMENTS OF I-123, I-124, I-131 IN NICKEL
od: Ohya, S, i dr.
Izdano: (1992)

Clinical manifestations of familial paraganglioma and phaeochromocytomas in succinate dehydrogenase B (SDH-B) gene mutation carriers.
od: Srirangalingam, U, i dr.
Izdano: (2008)

KFT 131 ï¿½ KIMIA FIZIK I APR 01.
od: PPSK, Pusat Pengajian Sains Kimia
Izdano: (2001)

KFT 131 ï¿½ KIMIA FIZIK I FEB 01.
od: PPSK, Pusat Pengajian Sains Kimia
Izdano: (2001)

Familial paraganglioma: a novel presentation of a case and response to therapy with radiolabelled MIBG.
od: Lawrence, J, i dr.
Izdano: (2004)

Multimodality palliative treatment of (111)In-pentetreotide negative/(123)I-MIBG positive metastatic carcinoid - a case report.
od: Dworakowska, D, i dr.
Izdano: (2008)

KFT 131 - PHYSICAL CHEMISTRY I APRIL 08.
od: PPSK, Pusat Pengajian Sains Kimia
Izdano: (2008)

KFT 131 - PHYSICAL CHEMISTRY I JUNE 08.
od: PPSK, Pusat Pengajian Sains Kimia
Izdano: (2008)

KFT 131 - KIMIA FIZIK I APRIL 04.
od: PPSK, Pusat Pengajian Sains Kimia
Izdano: (2004)

KFT 131 - KIMIA FIZIK I MAC 05.
od: PPSK, Pusat Pengajian Sains Kimia
Izdano: (2005)

KFT 131 - KIMIA FIZIK I APRIL 02.
od: PPSK, Pusat Pengajian Sains Kimia
Izdano: (2002)

KFT 131 - KIMIA FIZIK I APRIL 03.
od: PPSK, Pusat Pengajian Sains Kimia
Izdano: (2003)

KFT 131 - PHYSICAL CHEMISTRY I APRIL 07.
od: PPSK, Pusat Pengajian Sains Kimia
Izdano: (2007)

KFT 131 - PHYSICAL CHEMISTRY I JUNE 07.
od: PPSK, Pusat Pengajian Sains Kimia
Izdano: (2007)

KFT 131 - KIMIA FIZIK I APRIL 2000
od: PPSK, Pusat Pengajian Sains Kimia
Izdano: (2000)

KFT 131 - KIMIA FIZIK I APRIL 1999
od: PPSK, Pusat Pengajian Sains Kimia
Izdano: (1999)

KFT 131 - KIMIA FIZIK I FEB 98.
od: PPSK, Pusat Pengajian Sains Kimia
Izdano: (1998)

KFT 131 - KIMIA FIZIK I APRIL 98.
od: PPSK, Pusat Pengajian Sains Kimia
Izdano: (1998)

KFT 131 - KIMIA FIZIK I APRIL 1997.
od: PPSK, Pusat Pengajian Sains Kimia
Izdano: (1997)

NUCLEAR MAGNETIC-RESONANCE OF I-131 AND I-132 ORIENTED IN FE
od: James, P, i dr.
Izdano: (1974)

Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors.
od: Kaltsas, G, i dr.
Izdano: (2001)